Few studies have demonstrated the high degree of specificity, sensitivity, and accuracy of markers such as CEA, CA15-3 (cancer antigen 15-3), and CA19-9, with percentages ranging from 86 to 96% in the context of differentiating malignant from benign effusions [15,51]. Here, CEACAM5 is linked to cancer.